BELLUS Well being Inc. (TSE:BLU – Get Ranking) shares reached a brand new 52-week excessive throughout buying and selling on Wednesday . The inventory traded as excessive as C$13.79 and final traded at C$13.79, with a quantity of 32084 shares buying and selling arms. The inventory had beforehand closed at C$13.18.
Individually, HC Wainwright reaffirmed a “purchase” ranking and issued a C$16.00 value goal on shares of BELLUS Well being in a analysis report on Thursday, Might twelfth. 5 analysts have rated the inventory with a purchase ranking, Primarily based on information from MarketBeat, the inventory at present has a consensus ranking of “Purchase” and a consensus goal value of C$15.75.
The agency’s 50-day easy transferring common is C$10.72 and its 200 day easy transferring common is C$9.48. The corporate has a debt-to-equity ratio of 0.30, a fast ratio of 14.75 and a present ratio of 15.33. The inventory has a market capitalization of C$1.43 billion and a P/E ratio of -12.79.
BELLUS Well being (TSE:BLU – Get Ranking) final issued its quarterly earnings outcomes on Wednesday, Might eleventh. The corporate reported C($0.16) EPS for the quarter, topping the consensus estimate of C($0.23) by C$0.07. The enterprise had income of C$0.01 million for the quarter, in comparison with the consensus estimate of C$0.01 million. As a gaggle, analysis analysts anticipate that BELLUS Well being Inc. will submit -0.94 earnings per share for the present fiscal yr.
About BELLUS Well being (TSE:BLU)
BELLUS Well being Inc, a scientific stage biopharmaceutical firm, develops therapeutics for the remedy of refractory persistent cough (RCC) and different cough hypersensitivity indications. Its lead product candidate contains BLU-5937, an antagonist of the P2X3 receptor, which is in Part II scientific trial for remedy of RCC and persistent pruritus.
See Additionally
Need Extra Nice Investing Concepts?
Obtain Information & Rankings for BELLUS Well being Every day – Enter your e-mail deal with beneath to obtain a concise each day abstract of the most recent information and analysts’ rankings for BELLUS Well being and associated corporations with MarketBeat.com’s FREE each day e-mail publication.
